Patents by Inventor Guanglong SUN

Guanglong SUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compound
    Patent number: 11814371
    Abstract: The present application relates to the field of medicine. Specifically, disclosed are a compound of formula (I), a preparation method therefor, and a pharmaceutical composition comprising the compound.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: November 14, 2023
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Guanglong Sun, Chunli Shen, Chengde Wu, Shuhui Chen
  • HETEROCYCLIC COMPOUND
    Publication number: 20230167098
    Abstract: The present application relates to the field of medicine. Specifically, disclosed are a compound of formula (I), a preparation method therefor, and a pharmaceutical composition comprising the compound.
    Type: Application
    Filed: March 4, 2021
    Publication date: June 1, 2023
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: Guanglong SUN, Chunli SHEN, Chengde WU, Shuhui CHEN
  • BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR
    Publication number: 20230012570
    Abstract: Disclosed are a bicyclic compound used as a non-steroidal selective androgen receptor modulator and the use thereof in the preparation of a drug for treating related diseases which are mediated by an androgen receptor. Specifically, the present invention discloses a compound as shown in formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 20, 2019
    Publication date: January 19, 2023
    Inventors: Chunli SHEN, Guanglong SUN, Chengde WU, Shuhui CHEN